ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 수술용 지혈제 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년까지 CAGR 6.6%로 확대되어 50억 9,000만 달러로 성장할 것으로 예상됩니다. 이 예측 기간의 성장은 첨단 상처 봉합 제품에 대한 수요 증가, 외래수술센터(ASC) 확대, 생분해성 지혈제에 대한 선호도 증가, 지혈제 병용 사용 증가, 수술 개입이 필요한 생활 습관병의 이환율 증가에 의해 견인될 것으로 예측됩니다. 이 기간의 주요 동향으로는 흡수성 지혈제의 기술적 발전, 로봇 수술에 기술 통합, 차세대 지혈제 제제의 개발, 스마트 수술 기기 통합, 식물성 지혈제의 기술 혁신 등을 들 수 있습니다.
가까운 미래에 외상 사례 증가는 수술 지혈제 시장의 성장을 이끌 것으로 예측됩니다. 외상은 고통스러운 사건과 유해한 사건으로 인한 신체적 손상과 정신적 충격을 말하며 개인의 신체와 정신에 영향을 미칩니다. 외상 사례 증가는 주로 교통 사고의 급증으로 인한 것으로, 즉각적인 의료 치료가 필요한 중상을 일으킬 수 있습니다. 수술용 지혈제는 외상시 출혈을 빠르고 효과적으로 제어하고 출혈량을 줄여 환자를 안정시키고 추가 치료로 이어줍니다. 예를 들어, 2023년 위스콘신 주 보건 서비스국에 따르면 폭행으로 인한 외상은 2022년에 비해 3% 증가하여 1,544건에서 1,584건으로 증가했습니다. 따라서 외상 사례 증가가 수술용 지혈제 시장 확대에 박차를 가하고 있습니다.
수술용 지혈제 시장의 주요 기업은 흡수성 산화재생 셀룰로오스(ORC)와 같은 혁신적인 재료를 사용하여 첨단 제품을 개발하고 출혈 통제를 개선하고 상처 치유를 촉진하고 있습니다. 흡수성 산화재생 셀룰로오스는 수술 지혈제료에 사용되는 생분해성 식물 유래 재료로 상처 부위에 물리적 장벽을 만들어 혈전 형성을 촉진함으로써 출혈을 멈춥니다. 2022년 2월 인도의 의료기기 제조업체인 Futura Surgicare Pvt.Ltd.는 수술 중 효과적인 출혈 조절을 위해 설계된 첨단 흡수성 ORC 지혈제인 Hemostax를 발표했습니다. 본 제품은 1.5분 이내에 지혈을 시작하고 2-5분 내에 그 효과를 완료합니다. 1-2주간에 완전히 흡수되기 때문에 제거할 필요가 없습니다. Hemostax는 사용하기 쉽고 다양한 수술 부위에 적응하고, 비독성이고 생체적합성이 있으며, 약제 내성균에 대한 항균성을 가지고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 수술용 지혈제 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 수술용 지혈제 시장 : 성장률 분석
세계의 수술용 지혈제 시장 실적 : 규모와 성장, 2019-2024년
세계의 수술용 지혈제 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 수술용 지혈제 시장 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 수술용 지혈제 시장 : 제품 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
국소 트롬빈계 지혈제
유동성 지혈제
콜라겐계 지혈제
산화재생 셀룰로오스계 지혈제
젤라틴계 지혈제
복합 지혈제
기타
세계의 수술용 지혈제 시장 : 배합별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
매트릭스 및 겔 지혈제
스폰지 지혈제
시트 및 패드 지혈제
분말 지혈제
세계의 수술용 지혈제 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
신경외과
정형외과
심혈관 수술
부인과 수술
외상
성형외과
기타
세계의 수술용 지혈제 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
병원
외래수술센터(ASC)
전문 클리닉
기타
세계의 수술용 지혈제 시장 : 국소 트롬빈계 지혈제별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
인간 트롬빈계 지혈제
소 트롬빈계 지혈제
재조합 트롬빈계 지혈제
젤, 스프레이, 파우더, 스펀지 배합
세계의 수술용 지혈제 시장 : 유동성 지혈제별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
트롬빈 함유 젤라틴 매트릭스
콜라겐계 유동성 물질
합성 폴리머계 유동성 물질
세계의 수술용 지혈제 시장 : 콜라겐계 지혈제별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
미세섬유 콜라겐
부직포 콜라겐 패드
콜라겐 양털 또는 시트
세계의 수술용 지혈제 시장 : 산화 재생 셀룰로오스계 지혈제별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
직포 산화재생 셀룰로오스 섬유
부직포 산화재생 셀룰로오스 패드
첨가제 함유 산화 재생 셀룰로오스
세계의 수술용 지혈제 시장 : 젤라틴계 지혈제별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
젤라틴 스펀지
젤라틴 파우더
트롬빈 함유 젤라틴 폼
세계의 수술용 지혈제 시장 : 복합 지혈제별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
젤라틴 트롬빈
콜라겐 트롬빈
산화재생 셀룰로오스 트롬빈
세계의 수술용 지혈제 시장 : 기타 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
키토산계 지혈제
카올린계 지혈제
합성 펩티드 지혈제
식물 유래 약
제7장 지역별/국가별 분석
세계의 수술용 지혈제 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 수술용 지혈제 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
수술용 지혈제 시장 :경쟁 구도
수술용 지혈제 시장 : 기업 프로파일
Johnson And Johnson Services Inc.
Medtronic plc
Becton Dickinson And Company
Stryker Corporation
Baxter International Inc.
제31장 기타 주요 기업 및 혁신 기업
Teleflex Corporation
Integra LifeSciences Holdings Corporation
GELITA MEDICAL GmbH
B. Braun Melsungen AG
Advanced Medical Solutions Group plc
Axio Biosolutions Pvt. Ltd.
Marine Polymer Technologies Inc
Biom'up USA Inc
Lotus Surgicals Pvt. Ltd
Hemostasis LLC
Biocer Entwicklungs-GmbH
CuraMedical BV
EndoClot Plus Inc
Starch Medical Inc
Tricol Biomedical Inc
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 전략
수술용 지혈제 시장(2029년) : 새로운 기회를 제공하는 국가
수술용 지혈제 시장(2029년) : 새로운 기회를 제공하는 부문
수술용 지혈제 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
JHS
영문 목차
영문목차
Surgical hemostats are specialized tools or substances used during surgery to control bleeding by either clamping blood vessels or encouraging blood clot formation. Their purpose is to maintain a clear surgical area and minimize blood loss, improving visibility and safety throughout the procedure.
The primary types of surgical hemostats include topical thrombin-based hemostats, flowable hemostats, collagen-based hemostats, oxidized regenerated cellulose-based hemostats, gelatin-based hemostats, combination hemostats, and others. Topical thrombin-based hemostats are applied directly to bleeding areas to stimulate clotting by converting fibrinogen into fibrin through the action of thrombin. These come in various forms such as matrix and gel, sponges, sheets and pads, and powders. They are used in a wide range of surgeries including neurological, orthopedic, cardiovascular, gynecological, trauma, and plastic surgeries. These products are utilized by various end users including hospitals, ambulatory surgical centers, specialty clinics, and more.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The surgical hemostats market research report is one of a series of new reports from The Business Research Company that provides surgical hemostats market statistics, including surgical hemostats industry global market size, regional shares, competitors with a surgical hemostats market share, detailed surgical hemostats market segments, market trends and opportunities, and any further data you may need to thrive in the surgical hemostats industry. The surgical hemostats market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The surgical hemostats market size has grown strongly in recent years. It will grow from $3.68 billion in 2024 to $3.93 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. Growth during the historic period can be attributed to the rising number of surgical procedures, an increase in trauma and accident cases, a growing elderly population, greater adoption of minimally invasive surgical techniques, and a higher prevalence of chronic diseases.
The surgical hemostats market size is expected to see strong growth in the next few years. It will grow to $5.09 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. Growth in the forecast period is expected to be driven by increasing demand for advanced wound closure products, the expansion of ambulatory surgical centers, a growing preference for biodegradable hemostats, increased use of combination hemostatic agents, and a rising incidence of lifestyle-related diseases requiring surgical intervention. Key trends during this period include technological advancements in absorbable hemostats, integration of technology in robotic surgeries, development of next-generation hemostatic formulations, incorporation with smart surgical devices, and innovations in plant-based hemostatic products.
The increasing number of trauma cases is expected to drive the growth of the surgical hemostats market in the near future. Trauma involves physical injury or emotional shock resulting from a distressing or harmful event, affecting an individual's body or mind. The rise in trauma cases is mainly due to a surge in road traffic accidents, which cause severe injuries needing immediate medical care. Surgical hemostats assist in quickly and effectively controlling bleeding during trauma cases, reducing blood loss and stabilizing patients for further treatment. For example, in 2023, the Wisconsin Department of Health Services reported that traumatic injuries caused by assault increased by 3% compared to 2022, rising from 1,544 cases to 1,584 cases. Hence, the growing occurrence of trauma cases is fueling the expansion of the surgical hemostats market.
Leading companies in the surgical hemostats market are developing advanced products using innovative materials such as absorbable oxidized regenerated cellulose (ORC) to improve bleeding control and accelerate wound healing. Absorbable oxidized regenerated cellulose is a biodegradable, plant-derived material used in surgical hemostats to stop bleeding by creating a physical barrier and encouraging clot formation at the wound site. In February 2022, Futura Surgicare Pvt. Ltd., an India-based medical device manufacturer, introduced Hemostax, an advanced absorbable ORC hemostat designed for effective intraoperative bleeding control. This product initiates hemostasis within 1.5 minutes and completes its effect in 2 to 5 minutes. It is fully absorbed within 1 to 2 weeks, eliminating the need for removal. Hemostax is user-friendly, adapts well to various surgical sites, is non-toxic, biocompatible, and possesses antibacterial properties against drug-resistant bacteria.
In May 2025, Merit Medical Systems, Inc., a US-based medical device company, acquired Biolife Delaware for $120 million. Through this acquisition, Merit Medical Systems aims to broaden its hemostasis product portfolio and reinforce its position in the global market for rapid bleeding control solutions. BioLife Delaware, L.L.C. is a US-based medical device firm specializing in the development of surgical hemostatic products.
Major players in the surgical hemostats market are Johnson And Johnson Services Inc., Medtronic plc, Becton Dickinson And Company, Stryker Corporation, Baxter International Inc., Teleflex Corporation, Integra LifeSciences Holdings Corporation., GELITA MEDICAL GmbH, B. Braun Melsungen AG, Advanced Medical Solutions Group plc, Axio Biosolutions Pvt. Ltd., Marine Polymer Technologies Inc, Biom'up USA Inc, Lotus Surgicals Pvt. Ltd, Hemostasis LLC, Biocer Entwicklungs-GmbH, CuraMedical BV, EndoClot Plus Inc, Starch Medical Inc, Tricol Biomedical Inc.
North America was the largest region in the surgical hemostats market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in surgical hemostats report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the surgical hemostats market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The surgical hemostats market consists of sales of mechanical hemostats, active hemostats, flowable hemostats, fibrin sealants, and combination hemostats. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Surgical Hemostats Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on surgical hemostats market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for surgical hemostats ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The surgical hemostats market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Surgical Hemostats Market Characteristics
3. Surgical Hemostats Market Trends And Strategies
4. Surgical Hemostats Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Surgical Hemostats Growth Analysis And Strategic Analysis Framework
5.1. Global Surgical Hemostats PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Surgical Hemostats Market Growth Rate Analysis
5.4. Global Surgical Hemostats Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Surgical Hemostats Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Surgical Hemostats Total Addressable Market (TAM)
6. Surgical Hemostats Market Segmentation
6.1. Global Surgical Hemostats Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Thrombin-Based Hemostats
Flowable Hemostats
Collagen-Based Hemostats
Oxidized Regenerated Cellulose-Based Hemostats
Gelatin-Based Hemostats
Combination Hemostats
Other Product Types
6.2. Global Surgical Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Matrix And Gel Hemostats
Sponge Hemostats
Sheet And Pad Hemostats
Powder Hemostats
6.3. Global Surgical Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Neurological Surgery
Orthopedic Surgery
Cardiovascular Surgery
Gynecological Surgery
Trauma
Plastic Surgery
Other Applications
6.4. Global Surgical Hemostats Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Other End-Users
6.5. Global Surgical Hemostats Market, Sub-Segmentation Of Topical Thrombin-Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Human Thrombin-Based Hemostats
Bovine Thrombin-Based Hemostats
Recombinant Thrombin-Based Hemostats
Formulations Gel, Spray, Powder, Sponge
6.6. Global Surgical Hemostats Market, Sub-Segmentation Of Flowable Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gelatin Matrix With Thrombin
Collagen-Based Flowables
Synthetic Polymer-Based Flowables
6.7. Global Surgical Hemostats Market, Sub-Segmentation Of Collagen-Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Microfibrillar Collagen
Nonwoven Collagen Pads
Collagen Fleece Or Sheets
6.8. Global Surgical Hemostats Market, Sub-Segmentation Of Oxidized Regenerated Cellulose Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Woven Oxidized Regenerated Cellulose Fabric
Non-woven Oxidized Regenerated Cellulose Pads
Oxidized Regenerated Cellulose With Additives
6.9. Global Surgical Hemostats Market, Sub-Segmentation Of Gelatin-Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gelatin Sponge
Gelatin Powder
Gelatin Foam With Thrombin
6.10. Global Surgical Hemostats Market, Sub-Segmentation Of Combination Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gelatin + Thrombin
Collagen + Thrombin
Oxidized Regenerated Cellulose + Thrombin
6.11. Global Surgical Hemostats Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chitosan-Based Hemostats
Kaolin-Based Hemostats
Synthetic Peptide Hemostats
Plant-Derived Agents
7. Surgical Hemostats Market Regional And Country Analysis
7.1. Global Surgical Hemostats Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Surgical Hemostats Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
